![David Hung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hung
Fondateur chez
NUVATION BIO INC.
Fortune : 289 M $ au 31/05/2026
Profil
David T.
Hung was the founder of Medivation LLC (California), founded in 1995, where the titles held included President, Chief Executive Officer & Director from 2003 to 2016.
Dr. Hung was the founder of Medivation, Inc., founded in 2003, with titles of President, Chief Executive Officer & Director from 2003 to 2016.
Dr. Hung is the founder of Nuvation Bio Operating Co., Inc., founded in 2018, holding the titles of President, Chief Executive Officer & Director since 2018.
Dr. Hung is the founder of Nuvation Bio, Inc., founded in 2018, holding the titles of President, Chief Executive Officer & Director since 2018.
Dr. Hung is also the founder of Repharmation, Inc...
Dr. Hung currently serves as Chairman at T-Therapeutics Ltd. Dr. Hung is an Independent Director at NovoCure Ltd. since 2018.
Dr. Hung is a Director at Establishment Labs SA since 2016.
Dr. Hung is a Director at Auransa, Inc. Former positions include President & Chief Executive Officer at Orion Acquisition Corp.
II; President, Chief Executive Officer & Director at Pro-Duct Health, Inc. from 1999 to 2001; President, Chief Executive Officer & Director at Medivation Neurology LLC from 2011 to 2016; Chief Executive Officer & Director at Sio Gene Therapies, Inc. from 2017 to 2018; Chief Executive Officer & Director at Axovant Sciences, Inc. from 2017 to 2018; Director at Agilvax, Inc.; Director at Solbec Pharmaceuticals Ltd.; Independent Director at Opexa Therapeutics, Inc. from 2010 to 2011; Director at NKT Therapeutics, Inc.; Director at Roivant Sciences GmbH; Independent Director at Establishment Labs Holdings, Inc. from 2016 to 2021; Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2021; VP-Lead Discovery, Development & New Projects at Chiron Corp.
from 1996 to 1998; Consultant at Cytyc Health Corp.
in 2003.
Education includes undergraduate studies at Harvard College and a doctorate from UCSF School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 59 281 054 ( 17,02% ) | 283 M $ | 31/05/2026 | |
NUVATION BIO, INC. 6,37% | 25/03/2026 | 1 000 000 ( 6,37% ) | 5 M $ | 31/05/2026 |
NOVOCURE LTD. 0,03% | 03/06/2026 | 32 075 ( 0,03% ) | 546 558 $ | 31/05/2026 |
Postes actifs de David Hung
| Sociétés | Poste | Début |
|---|---|---|
| NOVOCURE LIMITED | Directeur/Membre du Conseil | 31/05/2018 |
| NUVATION BIO INC. | Fondateur | 20/03/2018 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Fondateur | 01/01/2018 |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Directeur/Membre du Conseil | - |
Repharmation, Inc. | Fondateur | - |
Establishment Labs SA
 Establishment Labs SA Medical SpecialtiesHealth Technology Designs, develops and manufactures breast health and wellness equipment | Directeur/Membre du Conseil | 01/02/2016 |
Anciens postes connus de David Hung
| Sociétés | Poste | Fin |
|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | Directeur/Membre du Conseil | 11/02/2021 |
| ARYA SCIENCES ACQUISITION CORP. | Directeur/Membre du Conseil | 01/01/2021 |
| SIO GENE THERAPIES INC. | Directeur Général | 12/02/2018 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Hung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Agilvax, Inc.
 Agilvax, Inc. BiotechnologyHealth Technology Develops vaccines for treatment of cancer immunotherapy | Health Technology |
Solbec Pharmaceuticals Ltd.
 Solbec Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops and markets therapies for life threatening and debilitating diseases | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
Medivation, Inc. /Old/
 Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Cytyc Health Corp. | |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnology products and services | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Establishment Labs SA
Establishment Labs SA Medical SpecialtiesHealth Technology Designs, develops and manufactures breast health and wellness equipment | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Health Technology |
Establishment Labs Holdings, Inc.
 Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Repharmation, Inc. | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
